Rankin Aubrey

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rankin Aubrey's trades of Revance Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-06 2021-12-03
B Purchase
35,442 -10.6%
410.75
US$454,244 		35,442 -10.6% 410.75 US$454,244
2021-04-06 2021-04-05
PlS Planned sale
13,129 +16.3%
344.82
US$2,513,397 		13,129 +16.3% 344.82 US$2,513,397
2021-03-05 2021-03-04
PlS Planned sale
99,867 -36.6%
124.09
US$2,558,744 		99,867 -36.6% 124.09 US$2,558,744
2021-02-03 2021-02-01
PlS Planned sale
33,119 -6.9%
25.95
US$859,438 		33,119 -6.9% 25.95 US$859,438
2021-01-04 2020-12-30
PlS Planned sale
33,119 -6.5%
27.82
US$921,212 		33,119 -6.5% 27.82 US$921,212
2020-12-02 2020-11-30
PlS Planned sale
33,119 -6.1%
23.85
US$789,888 		33,119 -6.1% 23.85 US$789,888
2020-10-30 2020-10-29
PlS Planned sale
33,119 -5.7%
26.15
US$865,949 		33,119 -5.7% 26.15 US$865,949